Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles

Priya Prakash Karmali, Ying Chao, Ji Ho Park, Michael J. Sailor, Erkki Ruoslahti, Sadik Esener, Dmitri Simberg

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Premature recognition and clearance of nanoparticulate imaging and therapeutic agents by macrophages in the tissues can dramatically reduce both the nanoparticle half-life and delivery to the diseased tissue. Grafting nanoparticles with hydrogels prevents nanoparticulate recognition by liver and spleen macrophages and greatly prolongs circulation times in vivo. Understanding the mechanisms by which hydrogels achieve this "stealth" effect has implications for the design of long-circulating nanoparticles. Thus, the role of plasma protein absorption in the hydrogel effect is not yet understood. Short-circulating dextran-coated iron oxide nanoparticles could be converted into stealth hydrogel nanoparticles by cross-linking with 1-chloro-2,3- epoxypropane. We show that hydrogelation did not affect the size, shape and zeta potential, but completely prevented the recognition and clearance by liver macrophages in vivo. Hydrogelation decreased the number of hydroxyl groups on the nanoparticle surface and reduced the binding of the anti-dextran antibody. At the same time, hydrogelation did not reduce the absorption of cationic proteins on the nanoparticle surface. Specifically, there was no effect on the binding of kininogen, histidine-rich glycoprotein, and protamine sulfate to the anionic nanoparticle surface. In addition, hydrogelation did not prevent activation of plasma kallikrein on the metal oxide surface. These data suggest that (a) a stealth hydrogel coating does not mask charge interactions with iron oxide surface and (b) the total blockade of plasma protein absorption is not required for maintaining iron oxide nanoparticles' long-circulating stealth properties. These data illustrate a novel, clinically promising property of long-circulating stealth nanoparticles.

Original languageEnglish (US)
Pages (from-to)539-545
Number of pages7
JournalMolecular Pharmaceutics
Volume9
Issue number3
DOIs
StatePublished - Mar 5 2012
Externally publishedYes

Fingerprint

Dextrans
Nanoparticles
Hydrogel
Hydrogels
Macrophages
Blood Proteins
ferric oxide
Plasma Kallikrein
Kininogens
Protamines
Liver
Masks
Hydroxyl Radical
Oxides
Half-Life
Anti-Idiotypic Antibodies
Spleen
Metals

Keywords

  • clearance
  • CLIO
  • iron oxide
  • kininogen
  • liver
  • nanoworms
  • plasma
  • SPIO
  • stealth

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles. / Karmali, Priya Prakash; Chao, Ying; Park, Ji Ho; Sailor, Michael J.; Ruoslahti, Erkki; Esener, Sadik; Simberg, Dmitri.

In: Molecular Pharmaceutics, Vol. 9, No. 3, 05.03.2012, p. 539-545.

Research output: Contribution to journalArticle

Karmali, Priya Prakash ; Chao, Ying ; Park, Ji Ho ; Sailor, Michael J. ; Ruoslahti, Erkki ; Esener, Sadik ; Simberg, Dmitri. / Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles. In: Molecular Pharmaceutics. 2012 ; Vol. 9, No. 3. pp. 539-545.
@article{cab91163a2944743b2b4a407c578b719,
title = "Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles",
abstract = "Premature recognition and clearance of nanoparticulate imaging and therapeutic agents by macrophages in the tissues can dramatically reduce both the nanoparticle half-life and delivery to the diseased tissue. Grafting nanoparticles with hydrogels prevents nanoparticulate recognition by liver and spleen macrophages and greatly prolongs circulation times in vivo. Understanding the mechanisms by which hydrogels achieve this {"}stealth{"} effect has implications for the design of long-circulating nanoparticles. Thus, the role of plasma protein absorption in the hydrogel effect is not yet understood. Short-circulating dextran-coated iron oxide nanoparticles could be converted into stealth hydrogel nanoparticles by cross-linking with 1-chloro-2,3- epoxypropane. We show that hydrogelation did not affect the size, shape and zeta potential, but completely prevented the recognition and clearance by liver macrophages in vivo. Hydrogelation decreased the number of hydroxyl groups on the nanoparticle surface and reduced the binding of the anti-dextran antibody. At the same time, hydrogelation did not reduce the absorption of cationic proteins on the nanoparticle surface. Specifically, there was no effect on the binding of kininogen, histidine-rich glycoprotein, and protamine sulfate to the anionic nanoparticle surface. In addition, hydrogelation did not prevent activation of plasma kallikrein on the metal oxide surface. These data suggest that (a) a stealth hydrogel coating does not mask charge interactions with iron oxide surface and (b) the total blockade of plasma protein absorption is not required for maintaining iron oxide nanoparticles' long-circulating stealth properties. These data illustrate a novel, clinically promising property of long-circulating stealth nanoparticles.",
keywords = "clearance, CLIO, iron oxide, kininogen, liver, nanoworms, plasma, SPIO, stealth",
author = "Karmali, {Priya Prakash} and Ying Chao and Park, {Ji Ho} and Sailor, {Michael J.} and Erkki Ruoslahti and Sadik Esener and Dmitri Simberg",
year = "2012",
month = "3",
day = "5",
doi = "10.1021/mp200375x",
language = "English (US)",
volume = "9",
pages = "539--545",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles

AU - Karmali, Priya Prakash

AU - Chao, Ying

AU - Park, Ji Ho

AU - Sailor, Michael J.

AU - Ruoslahti, Erkki

AU - Esener, Sadik

AU - Simberg, Dmitri

PY - 2012/3/5

Y1 - 2012/3/5

N2 - Premature recognition and clearance of nanoparticulate imaging and therapeutic agents by macrophages in the tissues can dramatically reduce both the nanoparticle half-life and delivery to the diseased tissue. Grafting nanoparticles with hydrogels prevents nanoparticulate recognition by liver and spleen macrophages and greatly prolongs circulation times in vivo. Understanding the mechanisms by which hydrogels achieve this "stealth" effect has implications for the design of long-circulating nanoparticles. Thus, the role of plasma protein absorption in the hydrogel effect is not yet understood. Short-circulating dextran-coated iron oxide nanoparticles could be converted into stealth hydrogel nanoparticles by cross-linking with 1-chloro-2,3- epoxypropane. We show that hydrogelation did not affect the size, shape and zeta potential, but completely prevented the recognition and clearance by liver macrophages in vivo. Hydrogelation decreased the number of hydroxyl groups on the nanoparticle surface and reduced the binding of the anti-dextran antibody. At the same time, hydrogelation did not reduce the absorption of cationic proteins on the nanoparticle surface. Specifically, there was no effect on the binding of kininogen, histidine-rich glycoprotein, and protamine sulfate to the anionic nanoparticle surface. In addition, hydrogelation did not prevent activation of plasma kallikrein on the metal oxide surface. These data suggest that (a) a stealth hydrogel coating does not mask charge interactions with iron oxide surface and (b) the total blockade of plasma protein absorption is not required for maintaining iron oxide nanoparticles' long-circulating stealth properties. These data illustrate a novel, clinically promising property of long-circulating stealth nanoparticles.

AB - Premature recognition and clearance of nanoparticulate imaging and therapeutic agents by macrophages in the tissues can dramatically reduce both the nanoparticle half-life and delivery to the diseased tissue. Grafting nanoparticles with hydrogels prevents nanoparticulate recognition by liver and spleen macrophages and greatly prolongs circulation times in vivo. Understanding the mechanisms by which hydrogels achieve this "stealth" effect has implications for the design of long-circulating nanoparticles. Thus, the role of plasma protein absorption in the hydrogel effect is not yet understood. Short-circulating dextran-coated iron oxide nanoparticles could be converted into stealth hydrogel nanoparticles by cross-linking with 1-chloro-2,3- epoxypropane. We show that hydrogelation did not affect the size, shape and zeta potential, but completely prevented the recognition and clearance by liver macrophages in vivo. Hydrogelation decreased the number of hydroxyl groups on the nanoparticle surface and reduced the binding of the anti-dextran antibody. At the same time, hydrogelation did not reduce the absorption of cationic proteins on the nanoparticle surface. Specifically, there was no effect on the binding of kininogen, histidine-rich glycoprotein, and protamine sulfate to the anionic nanoparticle surface. In addition, hydrogelation did not prevent activation of plasma kallikrein on the metal oxide surface. These data suggest that (a) a stealth hydrogel coating does not mask charge interactions with iron oxide surface and (b) the total blockade of plasma protein absorption is not required for maintaining iron oxide nanoparticles' long-circulating stealth properties. These data illustrate a novel, clinically promising property of long-circulating stealth nanoparticles.

KW - clearance

KW - CLIO

KW - iron oxide

KW - kininogen

KW - liver

KW - nanoworms

KW - plasma

KW - SPIO

KW - stealth

UR - http://www.scopus.com/inward/record.url?scp=84863258679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863258679&partnerID=8YFLogxK

U2 - 10.1021/mp200375x

DO - 10.1021/mp200375x

M3 - Article

VL - 9

SP - 539

EP - 545

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 3

ER -